Page 2 - பல்கலைக்கழகம் புற்றுநோய் ஆராய்ச்சி நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பல்கலைக்கழகம் புற்றுநோய் ஆராய்ச்சி நிதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பல்கலைக்கழகம் புற்றுநோய் ஆராய்ச்சி நிதி Today - Breaking & Trending Today

Investors pour $8M into Raleigh medical device startup; its drug delivery tech traces roots to UNC-CH

Investors pour $8M into Raleigh medical device startup; its drug delivery tech traces roots to UNC-CH
wraltechwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wraltechwire.com Daily Mail and Mail on Sunday newspapers.

United States , Menlo Park , North Carolina , University Of North Carolina , Bryan Martin , University Of North Carolina At Chapel Hill , National Institutes Of Health , Pioneer Award Program , Carolina Biotechnology Center Small Business Innovation , University Cancer Research Fund , Spectrum Financial , Chapel Hill , National Institutes , Pioneer Award , North Carolina Biotechnology Center , Small Business Innovation , Khosla Ventures , ஒன்றுபட்டது மாநிலங்களில் , மென்லோ பூங்கா , வடக்கு கரோலினா , பல்கலைக்கழகம் ஆஃப் வடக்கு கரோலினா , பிரையன் மார்டின் , பல்கலைக்கழகம் ஆஃப் வடக்கு கரோலினா இல் தேவாலயம் மலை , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , முன்னோடி விருது ப்ரோக்ர்யாம் , கரோலினா உயிரி தொழில்நுட்பவியல் மையம் சிறிய வணிக கண்டுபிடிப்பு ,

Advanced Chemotherapy Technologies, Inc. Announces $2.5M Series A Investment by Spectrum Financial

Press release content from Business Wire. The AP news staff was not involved in its creation.
Advanced Chemotherapy Technologies, Inc. Announces $2.5M Series A Investment by Spectrum Financial
February 11, 2021 GMT
Advanced Chemotherapy Technologies ACT-IOP-003 iontophoresis chemotherapy delivery system (Photo: Business Wire)
RALEIGH, N.C. (BUSINESS WIRE) Feb 10, 2021
Advanced Chemotherapy Technologies, Inc., a clinical-stage drug delivery company, announced today that it has closed a Series A investment of $2.5 million with Spectrum Financial. This investment is in addition to the previously announced Series A investment of $5.5 million lead by Khosla Venture. The capital will be used to fund initial clinical development of the company’s ACT-IOP-003 local chemotherapy system for the treatment of locally advanced non-resectable and borderline resectable pancreatic cancer. ....

North Carolina , United States , University Of North Carolina , Chapel Hill , Josephm Desimone , Jen Yeh , Bryan Martin , Carolina Biotechnology Center , Us National Institutes Of Health , Pioneer Award Program , Chemotherapy Technology , University Cancer Research Fund , Chemotherapy Technologies Inc , Lineberger Comprehensive Cancer Center , University Of North Carolina At Chapel Hill , Business Wire , Chief Investment Officer , Tony Voiers , Comprehensive Cancer , North Carolina Biotechnology Center , Pioneer Award , For More , Products And Services , Pancreatic Cancer , Product Testing , Diagnosis And Treatment ,

Study points the way to boost immunotherapy against breast cancer, other solid tumors

E-Mail
IMAGE: UNC Lineberger Comprehensive Cancer Center s Jonathan S. Serody, MD, and colleagues report that adding a small molecule to a chimeric antigen receptor-T (CAR-T) cell therapy can help immune system T.
view more
Credit: UNC Lineberger Comprehensive Cancer Center
CHAPEL HILL, NC Boosting immune system T cells to effectively attack solid tumors, such as breast cancers, can be done by adding a small molecule to a treatment procedure called chimeric antigen receptor-T (CAR-T) cell therapy, according to a study by researchers at the UNC Lineberger Comprehensive Cancer Center. The boost helps recruit more immune cells into battle at the tumor site. The findings are published in the ....

United States , Smith Kline , Soniaj Laurie , Nicholasp Restifo , Jonathans Serody , Benjamin Vincent , Douglasc Palmer , Caryn Willis , Alexanderc Robeson , Hemamalini Bommiasamy , School Of Medicine , Lyell Immunophara Inc , National Cancer Institute , University Cancer Research Fund , Merck Inc , Lineberger Comprehensive Cancer Center , Immunotherapy Program , National Heart , Blood Institute , Comprehensive Cancer , Elizabeth Thomas Professor , Peishun Shou , Gianpietro Dotti , Lyell Immunophara , National Cancer , University Cancer Research ,